This article includes discussion of benign adult familial myoclonic epilepsy, autosomal dominant cortical myoclonus and epilepsy, BAFME, familial adult myoclonic epilepsy, and familial cortical myoclonic tremor and epilepsy. The foregoing terms may include synonyms, similar disorders, variations in usage, and abbreviations.
Benign adult familial myoclonic epilepsy is an inherited epileptic syndrome characterized by cortical hand tremors, myoclonic jerks, and seizures with no signs of early dementia. Worldwide prevalence is unknown, but is estimated to be less than 1/35,000. It is transmitted autosomal dominantly, and penetrance is high. This is a well-delineated disease with remarkable features that clearly distinguish it from other forms of myoclonic epilepsies. Genetic studies of the families show heterogeneity, and different susceptible chromosomal loci have been identified. Diagnosis is based on clinical and electrophysiological findings. It must be differentiated from epilepsy syndromes with prominent myoclonus features. Valproate, levetiracetam, and benzodiazepines are the most beneficial treatments.
• Benign adult familial myoclonic epilepsy usually presents in the second decade of life with a minor cortical hand tremor exacerbated by fatigue or emotional stress. Myoclonus usually appears around the same age and consists of erratic, arrhythmic, segmental jerks of the upper limbs heightened by posture and action. Rare tonic-clonic seizures are also a manifestation and are often precipitated by photic stimulation, emotional stress, and sleep deprivation.
• Diagnosis is based on clinical and electrophysiological findings. EEG findings include a photomyoclonic response along with abnormality of polyspikes and waves. Patients also display extremely enlarged cortical components of somatosensory-evoked potentials and an enhanced C-reflex. Jerk-locked average analysis reveals positive-negative, biphasic spikes preceding myoclonus.
• Benign adult familial myoclonic epilepsy is transmitted autosomal dominantly, and it must be differentiated from idiopathic epilepsy syndromes with prominent myoclonus features (eg, juvenile myoclonic epilepsy or Janz syndrome) and from progressive myoclonic epilepsies.
• Valproate, levetiracetam, and benzodiazepines are most beneficial in the treatment of cortical tremors and myoclonus due to their combined antiepileptic and antimyoclonic effects. In some cases, epilepsy may be difficult to treat.
Historical note and terminology
The term “cortical tremor” was introduced by Ikeda and colleagues to indicate a postural and action-induced shivering movement of the hands mimicking essential tremor but showing the electrophysiological findings of cortical reflex myoclonus, that is: (1) brief EMG burst of about 50 msec duration; (2) no definite synchronisation or reciprocity in the antagonist muscles; (3) positive spikes preceding EMG bursts at the jerk-locked averaging; (4) enlarged cortical components of somatosensory-evoked potentials; (5) enhanced long-loop reflex I (or C-reflex) (Ikeda et al 1990).
Uyama and colleagues first reported a patient with adult-onset fine finger tremulous movement, myoclonic jerks, and 2 generalized seizures coming from a family that was affected with the same condition through 3 generations with high penetrance (Uyama et al 1985). None of the patients showed other neurologic signs nor abnormal neuroradiological findings; electrophysiological study indicated cortical reflex myoclonus. Subsequently, the same group reported 4 unrelated families, including 27 affected members through 3 generations with high penetrance (Uyama et al 2005). In 1991, Yasuda used the term "benign adult familial myoclonic epilepsy" (BAFME) to describe 2 pedigrees in which affected members showed autosomal dominant hand tremor, myoclonus, and epileptic seizures with a nonprogressive course (Yasuda 1991). Also in these patients, electrophysiological studies showed evidence of cortical reflex myoclonus. In 1999, Plaster and colleagues and Mikami and colleagues mapped the disease on chromosome 8q24 (Mikami et al 1999; Plaster et al 1999).
Although this condition was exclusively reported from Japan until the 1990s, several reports on pedigrees with similar clinical features but with different genetic identifiers appeared from different European countries and worldwide over the past decade with different names, such as autosomal dominant cortical myoclonus and epilepsy, familial adult myoclonic epilepsy, familial cortical myoclonic tremor, familial essential myoclonus and epilepsy, familial benign myoclonus epilepsy of adult onset, and heredofamilial tremor and epilepsy. Despite phenotypic and genetic differences, the clinical and electrophysiological data point toward one syndrome (Striano et al 2005; Striano and Zara 2016).
Genetic studies of families have revealed clinical and genetic heterogeneity with at least 4 loci, including 8q24 (FCMTE1), 2p11.1-q12.2 (FCMTE2), 5p15.31-p15.1 (FCMTE3), and 3q26.32-3q28 (FCMTE4) (see section 4).
The content you are trying to view is available only to logged in, current MedLink Neurology subscribers.
If you are a subscriber, please log in.
If you are a former subscriber or have registered before, please log in first and then click select a Service Plan or contact Subscriber Services. Site license users, click the Site License Acces link on the Homepage at an authorized computer.